FUJIFILM Irvine Scientific Presentation: Large-Scale Expansion of Human Mesenchymal Stromal/Stem Cells in Xeno-Free Conditions
Friday, May 31, 2024 12:45 PM - 01:00 PM
Exhibit Hall - Theatre A
Global Showcase Presentation
Presenter
Cell therapy developers focused on regenerative medicine rely on human mesenchymal stromal/stem cells (MSCs) for their ability to expand and differentiate across a variety of cell types. To generate high-quality MSCs in sufficient quantities for large-scale clinical trials, many cell therapy manufactures are moving from static to dynamic systems. MSC expansion in a closed sterile environment can help minimize risk of contamination, reduce production costs, and streamline the transition from research to clinical scale. Introducing a closed system, serum- and xeno-free, scalable solution for MSC expansion; PRIME-XV MSC XSFM Dual Component, an off-the-shelf product with media and supplement in an easy-to-use kit, designed for closed, automated, and scalable hollow-fiber systems.
Discover how PRIME-XV MSC XSFM Dual Component capabilities:
• Maximize MSC expansion to clinically relevant doses
• Reduce risk of contamination with closed-system processing
• Minimize variability in MSC expansion in xeno- and serum-free conditions
• Simplify and expedite MSC expansion at scale
- Anastassia A. Tselikova, Senior Scientist I, R&D, Cell and Gene Therapy, FUJIFILM Irvine Scientific, USA
Cell therapy developers focused on regenerative medicine rely on human mesenchymal stromal/stem cells (MSCs) for their ability to expand and differentiate across a variety of cell types. To generate high-quality MSCs in sufficient quantities for large-scale clinical trials, many cell therapy manufactures are moving from static to dynamic systems. MSC expansion in a closed sterile environment can help minimize risk of contamination, reduce production costs, and streamline the transition from research to clinical scale. Introducing a closed system, serum- and xeno-free, scalable solution for MSC expansion; PRIME-XV MSC XSFM Dual Component, an off-the-shelf product with media and supplement in an easy-to-use kit, designed for closed, automated, and scalable hollow-fiber systems.
Discover how PRIME-XV MSC XSFM Dual Component capabilities:
• Maximize MSC expansion to clinically relevant doses
• Reduce risk of contamination with closed-system processing
• Minimize variability in MSC expansion in xeno- and serum-free conditions
• Simplify and expedite MSC expansion at scale
SPONSORED BY:
